FSD Pharma Inc.(CSE: HUGE,
OTCQB: FSDDF,
Forum) is focused on the research and development of novel cannabinoid-based treatments for several central nervous system disorders including chronic pain, fibromyalgia and irritable bowel syndrome, and on the development of the highest quality indoor grown, pharmaceutical-grade cannabis.
'HUGE' is a publicly-traded company and through its wholly-owned subsidiary holds an 'Access to Cannabis for Medical Purposes Regulation' license to cultivate cannabis. It is engaged in the production and sale of medical cannabis.
All of the company's operations are situated in Canada.
(Click here to play video)
FULL DISCLOSURE: This is a paid article produced by Stockhouse Publishing